RecruitingNot ApplicableNCT03217110

Cerebellar Stimulation and Cognitive Control

Cerebellar Transcranial Magnetic Stimulation and Cognitive Control


Sponsor

Krystal Parker, PhD

Enrollment

200 participants

Start Date

Nov 30, 2017

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to examine whether cerebellar stimulation can be used to improve cognitive deficits and mood in patients with schizophrenia, autism, bipolar disorder, Parkinson's disease, and major depression.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is using non-invasive brain stimulation (targeting the cerebellum, the part of the brain at the back of the skull) to investigate how it affects thinking and self-control in people with certain neurological or psychiatric diagnoses. **You may be eligible if...** - You have a clinical diagnosis that the research team has determined makes you eligible for enrollment - You are able to give informed consent **You may NOT be eligible if...** - You have a history of recurrent seizures or epilepsy - You have any other neurological or psychiatric diagnosis beyond the one you are being enrolled for - You have had active substance use disorder in the past 6 months (except tobacco) - You have a pacemaker, heart stent, defibrillator, or neurostimulator device - You are claustrophobic, have uncontrolled high blood pressure, atrial fibrillation, significant heart disease, kidney disease, or are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERepetitive Transcranial Magnetic Stimulation (rTMS)

Subjects with neuropsychiatric diagnoses and matched-controls will be receive theta frequency stimulation of the cerebellum. We will target the cerebellar vermis.

DEVICESham Repetitive Transcranial Magnetic Stimulation (rTMS)

Subjects with neuropsychiatric diagnoses and matched-controls will be receive sham stimulation of the cerebellum. We will target the cerebellar vermis.


Locations(1)

University of Iowa

Iowa City, Iowa, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03217110


Related Trials